People · Operator
Named in public records as an officer, director or promoter · active 2014–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bio Blast Pharma Ltd. | — | Pharmaceuticals | Series A | $11.4M | $207.5M | 2014 |
Ran Nusbaum at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ran Nusbaum on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Colin Foster | 1 | 3 |
| Dalia Megiddo | 1 | 3 |
| Udi Gilboa | 1 | 2 |
| Thomas I. H. Dubin | 1 | 2 |
| ROBERT COOK | 1 | 2 |
| Fredric Price | 1 | 2 |
| Leigh M. Cherry | 1 | 1 |
| Isaac I. H. Krymolowski | 1 | 1 |
| Gili M. Cohen | 1 | 1 |
| Marlene Haffner | 1 | 1 |
| Yaron Daniely | 1 | 1 |
| Paul Firuta | 1 | 1 |
| Theresa M. Stevens | 1 | 1 |
| Dalia I. H. Megiddo | 1 | 1 |
| Warren Wasiewski | 1 | 1 |
| Michael M. Burshtine | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.